Phyx, a universal platform for selective sample enrichment, named finalist for the SLAS2026 New Product Award Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today ...

The gene fusion testing market offers opportunities in developing advanced technologies like next-generation sequencing (NGS) ...

A new technique brings CRISPR-mediated gene editing together with spatial transcriptomics and imaging to study the ...

A new study finds that prenatal exposure to bisphenol A (BPA), a common plastic chemical, may permanently feminise males and masculinise females, altering metabolism, immunity and disease risk later ...

Biological differences between women and men led to variations in the appearance and progression of many diseases, which influenced diagnosis and response to treatments.

Parvovirus B19 directly infects haematopoietic stem cells, impairing blood formation. Inhibition of JAK2 STAT5 with ...

Proteins circulating in the blood could accelerate the aging of blood vessels and increase silent cardiac risk.

HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...

Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Complex human diseases—such as cancer, neurodegenerative disorders, autoimmune conditions, cardiometabolic disease, and chronic inflammatory syndromes—arise ...

Postoperative recurrence (POR) is a major challenge in the long-term management of Crohn’s disease (CD), affecting up to 70% ...